Inovalon Holdings (INOV) has been under a strong bear grip, hence the stock is down -24.26% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.84% in the past 1 week. The stock has risen by 0.89% in the past week indicating that the buyers are active at lower levels, but the stock is down -23.48% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 15.51% and the 50-Day Moving Average is 17.48%. Inovalon Holdings (NASDAQ:INOV): On Fridays trading session , Opening price of the stock was $14.75 with an intraday high of $14.77. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $14.54. However, the stock managed to close at $14.73, a loss of 0.14% for the day. On the previous day, the stock had closed at $14.75. The total traded volume of the day was 745,815 shares.
The company Insiders own 50.71% of Inovalon Holdings shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -8% . Institutional Investors own 30.32% of Inovalon Holdings shares. During last six month period, the net percent change held by insiders has seen a change of 0.53%. Also, Brokerage firm PiperJaffray downgrades its rating on Inovalon Holdings (NASDAQ:INOV). The shares have been rated Underweight. Previously, the analysts had a Neutral rating on the shares. The rating by the firm was issued on August 4, 2016.
Inovalon Holdings, Inc. is a technology company. The Company combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Through its datasets, integration technologies, predictive analytics and subject matter expertise, the Company delivers platforms. Its analytics identify gaps in care, quality, data integrity, and financial performance, while providing clients with capabilities to resolve these gaps. The Companys data analytics and intervention platforms consist of four primary components: data integration, advanced analytics, intervention platforms and business processing. This system manages the process of defining and configuring industry data feeds from its clients and partners, including electronic health records, laboratory, pharmacy, patient reported, claims, paper based medical records, biometric, and hospital data feeds.